Compare ALKS & CHE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | ALKS | CHE |
|---|---|---|
| Founded | 1987 | 1970 |
| Country | Ireland | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Medical/Nursing Services |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 7.8B | 6.7B |
| IPO Year | 2012 | 1994 |
| Metric | ALKS | CHE |
|---|---|---|
| Price | $45.35 | $547.19 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 20 | 5 |
| Target Price | $57.74 | ★ $617.00 |
| AVG Volume (30 Days) | ★ 1.4M | 130.3K |
| Earning Date | 11-03-2026 | 10-27-2026 |
| Dividend Yield | N/A | ★ 0.51% |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ 15.43 |
| Revenue | $1,475,899,000.00 | ★ $2,529,978,000.00 |
| Revenue This Year | $23.60 | $8.05 |
| Revenue Next Year | $5.69 | $6.63 |
| P/E Ratio | ★ N/A | $35.73 |
| Revenue Growth | N/A | ★ 4.06 |
| 52 Week Low | $27.00 | $365.21 |
| 52 Week High | $55.67 | $562.24 |
| Indicator | ALKS | CHE |
|---|---|---|
| Relative Strength Index (RSI) | 49.36 | 58.82 |
| Support Level | $44.07 | $495.36 |
| Resistance Level | $45.20 | $555.98 |
| Average True Range (ATR) | 1.83 | 13.85 |
| MACD | -0.13 | 0.10 |
| Stochastic Oscillator | 25.56 | 69.09 |
Alkermes PLC is a fully integrated biotechnology company that applies its proprietary technologies to research, develop, and commercialize pharmaceutical products designed for unmet medical needs in therapeutic areas. The company utilizes several to develop and commercialize products and, in so doing, access technological, financial, marketing, manufacturing, and other resources. Alkermes either purchases active drug products from third parties or receives them from its third-party licensees to formulate products using its technologies. It operates in U.S., which derives maximum revenue, Ireland and Rest of the world.
Chemed Corp purchases, operates, and divests subsidiaries engaged in diverse business activities to maximize shareholder value. The company operates in the following segments: VITAS and Roto-Rooter. The VITAS segment generates the majority of the firm's revenue and provides hospice and palliative care services to patients with terminal illnesses through a network of physicians, registered nurses, home health aides, social workers, and volunteers. The Roto-Rooter segment provides plumbing, drain cleaning, water restoration, and related services to residential and commercial customers.